For example, mutations in the p53 tumor suppressor gene or disrupted functions of p53 protein have been found to be responsible for treatment failure and poor prognosis in B- and T-cell Non-Hodgkin’s lymphoma [23, 24]. This evidence concerns the gene TP53 and T-cell non-Hodgkin lymphoma.